ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

Depression, Anxiety and Suicidal Thoughts In a Cohort Of Pediatric Lupus and Mixed Connective Tissue Disease Patients

Andrea Knight1, Pamela F. Weiss2, Knashawn Morales3 and Ron Keren4, 1Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA, 4Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Anxiety, depression and pediatric rheumatology, Lupus

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects II: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Emerging data reveals that depression and anxiety disorders are highly prevalent in adult patients with systemic lupus erythematosus (SLE). These disorders are associated with increased healthcare utilization and poor outcomes. The prevalence of depression and anxiety disorders and their effect on children with lupus is unclear. We therefore aimed to characterize depression and anxiety in a cohort of children with SLE and the lupus-like syndrome of mixed connective tissue disease (MCTD). 

Methods: The study is a cross-sectional analysis of pediatric-onset SLE and MCTD patients followed by CHOP rheumatology and nephrology. Subjects were consecutively recruited and consented at outpatient clinic visits. The presence of depression and anxiety disorders was measured by Patient Health Questionnaire 9 (PHQ-9) and the Screen for Child Anxiety Related Disorders (SCARED), using iPads and REDCap database technology. Scores of >=5 on the PHQ-9 and >=25 on the SCARED identified depression and anxiety symptoms, respectively, and educational handouts with psychiatric referral were given for subjects with positive screens. In addition, positive screens for suicide risk on the PHQ-9 were administered a suicide prevention protocol. Demographic characteristics as well as mental health history, disease duration, manifestations, medications, and activity were also measured.   

Results: Forty-five patients were recruited, of which 38 had SLE and 7 had MCTD. The mean age of the study cohort was 15.6 years (SD 3.1) and 87% were female. The median PHQ-9 score was 4 (IQR 1,12) and depressive symptoms were identified in 9 patients (20%). Suicidal thoughts in the past 2 weeks were identified in 7 patients (16%), however, none required emergent psychiatric intervention. The mean SCARED score was 17.4 (SD 10.9) and anxiety symptoms were identified in 10 patients (22%).

Conclusion: Depression and anxiety symptoms, as well as recent suicidal thoughts were prevalent in the study cohort of children with pediatric lupus and MCTD, at frequencies higher than those reported in the general pediatric and adolescent population. Further investigation is needed to characterize the effects of these symptoms on clinical outcomes, quality of life and healthcare utilization.


Disclosure:

A. Knight,
None;

P. F. Weiss,
None;

K. Morales,
None;

R. Keren,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-anxiety-and-suicidal-thoughts-in-a-cohort-of-pediatric-lupus-and-mixed-connective-tissue-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology